Abstract:Objective To analyze the detection rate of HBV serological makers in non-hepatic inpatients in the past six years. Methods Serum samples of 70 582 non-hepatic inpatients from three large hospitals were collected during 2003 to 2008. Serological markers of HBV ( HBsAg, anti-HBs, HBeAg, antiHBe and anti-HBc) were detected by the AxSYM MEIA system (Abbott Laboratories,Abbott Park,IL).Combining the test results of serological makers with other clinical data, several analysis models for this retrospective study were set up to evaluate the year-to-year changes in serological makers and the detection rates of each model. Results The order from high to low of detection rate of the 5 HBV serological markers was anti-HBc (55. 17% ), anti-HBs (49. 57% ), anti-HBe (28.42%), HBsAg ( 8. 92% ) and HBeAg (2. 12% ), and all of them had a downward trend in the past six years. The positive rate of HBsAg went down from 9. 30% (2003) to 8.70% (2008). The positive rate of HBsAg among people who were born after 1992 (2. 28% ) were significantly lower than that of the overall population (8. 92% ) and fell from 3.57%(2003) to 1.85% (2008). Each detection rate of all serological makers had male sexual side effect [HBsAg ( 12. 38%/7. 25% ), HBeAg ( 2. 72%/1.58% ), anti-HBc ( 56. 57%/53.43% ), anti-HBe (41.50%/28. 35% ) and anti-HBs (65.48%/50. 00% ), male/female]. The differences were statistically significant (Chi-square values of HBsAg, HBeAg, anti-HBc, anti-HBe and anti-HBs were 509.74,105.78, 69.66, 1 321.61 and 1 726.91, respectively; all P ＜ 0. 01).Twenty-six models of HBV serological makers from 70 582 inpatients were summed up, and 8 models had positive rates geater than or equal to 1%. The "All Negative" model ranked No. 1 and had no significant change from year to year. During the past six years, models representing "A11 Negative" and "anti-HBs Positive alone" were mainly in individuals younger than or equal to 20-year-old, while the models representing "anti-HBc and/or anti-HBe,anti-HBs Positive" were mostly in people older than 20-year-old. The distribution curve of models representing "HBsAg, HbeAg and anti-HBc Positive" and "HBsAg, anti-HBc, anti-HBe Positive"etc. showed a bell-shape, covering the population from 20-year-old to 70-year-old. Conclusions The slowlydescending tendency of the detection rates of HBV serological makers was observed during the past six years.The detection rates of HBV in the younger generation decreased significantly. However, the HBV infection rates of overall population is still high, so it is a high time that we made continuous improvement for the serum HBV screening technique in order to reduce the HBV infection ratess.

Meta-analysis of the Immunization with Hepatitis B Gene Vaccine on Adults and Vaccination Necessity of Adult

Retrospective Analysis of Hepatitis B Virus Serological Markers in 70 582 Inpatients

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis.

Factors influencing immunologic response to hepatitis B vaccine in adults

Immune Response to Hepatitis B Vaccine in Children Born to HBsAg Positive Mothers: a Meta-Regression Analysis

Immunological Effects of a 10-Μg Dose of Domestic Hepatitis B Vaccine in Adults

Suitable Hepatitis B Vaccine for Adult Immunization in China

Evaluation of the Effect of Enhanced Immunization in Adults: A Cross-Sectional Study in the Southeast City of China

The Response of Hepatitis B Vaccination on Seronegative Adults with Different Vaccination Schedules.

Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China

Healthy Adult Vaccination: An Urgent Need To Prevent Hepatitis B In China

Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.

Survey of Hepatitis B Vaccination Coverage and Surface Antibody-Positive Rates in People Aged 1-59 Years in 2006 and 2024

Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.

The Effect of Hepatitis B Vaccination after Five Years on an Entire Population in an Insular Region of Southeast China

A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.

Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review

The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: a 5-year follow-up study.

Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults

Strategies for Hepatitis B Booster Vaccination among Children: an 8-Year Prospective Cohort Study